Jacobi Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Jacobi Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5	Closed	–	–	469
2021 Q3	$0	Hold	5	–	–	﹤0.01%	1436
2021 Q2	$0	Hold	5	–	–	﹤0.01%	1380
2021 Q1	$0	Hold	5	–	–	﹤0.01%	1350
2020 Q4	$0	Hold	5	–	–	﹤0.01%	1295
2020 Q3	$0	Hold	5	–	–	﹤0.01%	1246
2020 Q2	$0	Hold	5	–	–	﹤0.01%	1216
2020 Q1	$0	Hold	5	–	–	﹤0.01%	1126
2019 Q4	$0	Hold	5	–	–	﹤0.01%	1062
2019 Q3	$0	Hold	5	–	–	﹤0.01%	1043
2019 Q2	$0	Hold	5	–	–	﹤0.01%	1034
2019 Q1	$0	Hold	5	–	–	﹤0.01%	979
2018 Q4	$0	Hold	5	–	–	﹤0.01%	957
2018 Q3	$0	Hold	5	–	–	﹤0.01%	976
2018 Q2	$0	Hold	5	–	–	﹤0.01%	1007
2018 Q1	$0	Hold	5	–	–	﹤0.01%	979
2017 Q4	$0	Hold	5	–	–	﹤0.01%	918
2017 Q3	$0	Hold	5	–	–	﹤0.01%	903
2017 Q2	$0	Hold	5	–	–	﹤0.01%	826
2017 Q1	$0	Hold	5	–	–	﹤0.01%	691
2016 Q4	$0	Hold	5	–	–	﹤0.01%	616
2016 Q3	$0	Hold	5	–	–	﹤0.01%	716
2016 Q2	$0	Buy	+5	New	+$243	﹤0.01%	712

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jacobi Capital Management's ANIP Position: Q4 2021 in Review

Jacobi Capital Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2021, closing a stake of 5 shares.

Jacobi Capital Management first reported a position in ANIP in Q2 2016 and held it in 22 quarters. The position peaked at $0 in Q3 2021. 132 funds tracked by Wall St. Rank hold ANIP as of Q4 2021.

Jacobi Capital Management reported no remaining ANI Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 5 ANI Pharmaceuticals shares in Q4 2021.
Jacobi Capital Management first reported a position in ANI Pharmaceuticals in Q2 2016 and held it in 22 quarters.
Jacobi Capital Management's ANI Pharmaceuticals position peaked at $0 in Q3 2021.
132 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.